DSM-Firmenich, CH1216478797

DSM-Firmenich stock completes EUR 540 million buyback

Published on 10/07/2026 at 14:18 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

DSM-Firmenich stock was trading at EUR 99.90 on October 7, 2026, close to its EUR 100.50 52-week high. The completed buyback covers EUR 540 million.

Börsen-Editorialfoto vom Trading-Floor mit Charts und Molekülgrafiken
dsm-firmenich AG (ISIN CH1216478797) notiert an der SIX, als Editorial-Szene vom Börsen-Trading-Floor mit Charts dargestellt, Illustration mit AI erstellt.

DSM-Firmenich stock (ISIN CH1216478797) was trading at EUR 99.90 on Euronext Amsterdam on October 7, 2026, up 0.28 percent and 0.60 percent below its 52-week high of EUR 100.50. The company has completed a EUR 540 million share repurchase program, giving the stock a concrete capital-return catalyst.

Buyback reduces the share base

According to dsm-firmenich on October 1, 2026, the program repurchased 7,169,147 shares at an average price of EUR 75.32. Of those shares, 6,488,446 are intended for cancellation by the end of the first quarter of 2027.

The cancellation is designed to reduce the issued share count from 253,626,947 to 247,138,501 shares. That makes the buyback more than a cash distribution story because the planned cancellation changes the denominator used for future per-share figures.

H1 margin reached 19.3 percent

The latest operating picture came from the half-year results published on July 30, 2026. De Belegger reported continuing-operations revenue of EUR 4.66 billion for H1 2026, 5 percent like-for-like growth and adjusted EBITDA of EUR 900 million at a 19.3 percent margin.

The comparison is mixed in quality: comparable sales grew 5 percent, while adjusted EBITDA increased 7 percent on a comparable basis, but first-half gross cash conversion was 7 percent against a full-year target of 11 percent to 12 percent. For investors, that gap makes cash generation the key counterweight to the margin story.

Consensus stays below the share price

MarketScreener listed an Outperform consensus from 20 analysts on September 23, 2026. The average target was EUR 93.62, with a high target of EUR 117.00 and a low target of EUR 67.00, placing the current market price above the published average.

The next scheduled business update is November 4, 2026, according to MarketScreener. That date gives the market a defined checkpoint for cash conversion, volume growth and the effect of the reduced share count.

Stock stays below yearly high

DSM-Firmenich stock was last at EUR 99.90 on Euronext Amsterdam on October 7, 2026 at 2:01 p.m. CEST. The market capitalization was EUR 24.7 billion, with 97,666 shares traded and a 52-week range of EUR 55.22 to EUR 100.50.

DSM-Firmenich stock details

  • Company: DSM-Firmenich AG
  • ISIN: CH1216478797
  • Ticker: DSFIR
  • Trading venue: Euronext Amsterdam
  • Price (as of October 7, 2026, 2:01 p.m. CEST): EUR 99.90
  • Market capitalization: EUR 24.7 billion (as of October 7, 2026)
  • 52-week range: EUR 55.22-100.50 (as of October 7, 2026)
  • Volume: 97,666 shares (as of October 7, 2026)
  • Sector / Industry: Materials

Upcoming dates for DSM-Firmenich stock

  • November 4, 2026: Q3 2026 business update

More news and analyses on DSM-Firmenich stock

Disclaimer...

en | CH1216478797 | DSM-FIRMENICH | boerse | 70255631 | bgmi